Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

Researchers examined both clinical isolates and laboratory strains of Mycobacterium tuberculosis, the bacteria that causes TB. The researchers used a systems biology approach, combining genetic ...

A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...

Low treatment compliance contributes directly to the emergence of multidrug- and extensively drug–resistant (MDR and XDR) strains of Mycobacterium tuberculosis, which further limit the efficacy ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital ...

In the bacterium M. smegmatis, an enzyme called MftG allows the cofactor mycofactocin to transfer electrons released during ethanol metabolism to the electron transport chain.

Researchers have developed an RNA-seq method for investigating drug-resistant infections, and we got the inside scoop!

A safe vaccine called BCG, consisting of a weakened strain of the closely related Mycobacterium bovis, has been available for over a century but has limited efficacy. "BCG protects children from ...